Serotonin syndrome associated with triptan monotherapy

New England Journal of Medicine

Volumn 358, Issue 20, 2008, Pages 2185-2186

  Soldin, Offie P ^a   Tonning, Joseph M ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

AGITATION; CLINICAL FEATURE; DRUG MARKETING; FLUSHING; FOOD AND DRUG ADMINISTRATION; HEALTH STATUS; HEART PALPITATION; HUMAN; HYPERTENSION; LETTER; MIGRAINE; MONOTHERAPY; MUSCULOSKELETAL STIFFNESS; PRESCRIPTION; PRIORITY JOURNAL; SEROTONIN SYNDROME; TREMOR;

EID: 43549116837     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0706410     Document Type: Letter

References (3)

1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112-20. [Erratum, N Engl J Med 2007;356:2437.]
2. DA Sclar LM Robison TL Skaer Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome. Headache 48 2008 126 129
3. GK Isbister NA Buckley IM Whyte Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust 187 2007 361 365